Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Climacteric complaints as influenced by progestogens.

B von Schoultz

    Maturitas
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Progestogens offer a potential treatment for menopausal symptoms, with evidence suggesting benefits for both vasomotor and mental complaints. This review assesses their overall usefulness in managing climacteric issues.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Expression of cyclooxygenase-1 and cyclooxygenase-2, syndecan-1 and connective tissue growth factor in benign and malignant breast tissue from premenopausal women.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2017
    Same author

    Peak bone mineral density in Vietnamese women.

    Archives of osteoporosis·2010
    Same author

    IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone.

    Reproductive biomedicine online·2009
    Same author

    Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys.

    Climacteric : the journal of the International Menopause Society·2008
    Same author

    Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.

    Maturitas·2008
    Same author

    Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.

    Breast (Edinburgh, Scotland)·2007
    Same journal

    Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices.

    Maturitas·2026
    Same journal

    Mobility limitation trajectories and longitudinal changes in delayed recall in midlife and later life: A multicohort study.

    Maturitas·2026
    Same journal

    Digital twins in menopause: a roadmap for integrating endocrine dynamics, multisystem physiology, and precision medicine.

    Maturitas·2026
    Same journal

    Testosterone therapy in women: Keeping pace with the evidence.

    Maturitas·2026
    Same journal

    Diagnosis and management of androgen excess presenting after menopause.

    Maturitas·2026
    Same journal

    Domain-specific severity of menopausal symptoms and emotional eating in midlife women.

    Maturitas·2026
    See all related articles

    Area of Science:

    • Reproductive endocrinology
    • Menopause research
    • Pharmacological treatments for women's health

    Background:

    • Menopause is characterized by various symptoms, including vasomotor and mental disturbances.
    • Hormone therapy is a common approach to managing menopausal complaints.
    • Progestogens are a class of hormones with potential therapeutic applications during menopause.

    Purpose of the Study:

    • To conduct a general assessment of progestogen efficacy in treating menopausal complaints.
    • To review existing literature on progestogen use for climacteric symptoms.
    • To separately evaluate the impact of progestogens on vasomotor and mental symptoms.

    Main Methods:

    • Literature review and evidence synthesis.
    • Analysis of studies investigating progestogen treatment for menopausal symptoms.

    Related Experiment Videos

  • Separate examination of effects on vasomotor and mental symptoms.

    • Main Results:

    • Progestogens demonstrate varying degrees of usefulness in alleviating menopausal complaints.
    • Evidence suggests a role for progestogens in managing vasomotor symptoms.
    • The impact of progestogens on mental symptoms associated with menopause is also considered.

    Conclusions:

    • Progestogens represent a viable therapeutic option for certain menopausal symptoms.
    • Further research may refine the understanding of optimal progestogen use in climacteric management.
    • Individualized treatment approaches considering both symptom type and progestogen effects are warranted.